|
|
|
|
renal protective effects of oral achillea millefolium in patients with type 2 diabetes: a double-blind, randomized, placebo-controlled trial
|
|
|
|
|
|
|
|
نویسنده
|
daneshvar-ghahfarokhi shole ,mohammadi-shahrokhi vahid
|
|
منبع
|
journal of preventive and complementary medicine - 2025 - دوره : 4 - شماره : 3 - صفحه:150 -156
|
|
چکیده
|
Background: diabetic kidney disease is a highly prevalent and serious long-term complication of type 2 diabetes mellitus (t2dm). phytotherapeutic interventions are increasingly explored as adjunctive therapies. achillea millefolium (am), a traditional medicinal plant, has been postulated to possess renoprotective properties.objectives: this study aimed to investigate the efficacy and renoprotective effects of am supplementation on serum urea and creatinine levels in patients with t2dm as an adjunct therapy.methods: in this double-blind, randomized, placebo-controlled trial (irct20230612058459n1), we enrolled 60 patients with t2dm. participants were randomly assigned to receive either 500 mg/day of an am capsule (n=30) or an identically appearing placebo (cellulose) capsule (n=30) for three months. serum urea and creatinine concentrations were measured at baseline and after the intervention. results: following the three-month intervention, the am group exhibited significant within-group reductions in both serum creatinine (from 1.17 ± 0.36 mg/dl to 0.84 ± 0.15 mg/dl; p < 0.0001) and serum urea (from 37.7 ± 10.02 mg/dl to 30.93 ± 6.12 mg/dl; p < 0.0001). in the placebo group, changes in these parameters were not statistically significant. however, the between-group analysis revealed that the post-intervention reductions in serum creatinine and urea in the am group were not statistically significantly different from those observed in the placebo group (p = 0.117 and p = 0.221, respectively).conclusion: our results demonstrate that a three-month supplementation with 500 mg/day of am significantly reduces serum creatinine and urea levels from baseline in patients with t2dm. however, the lack of a statistically significant between-group difference compared to placebo tempers the conclusion of efficacy, suggesting that the observed effect may not be attributable solely to the active intervention. further large-scale studies are warranted to confirm these findings and elucidate the underlying mechanisms.
|
|
کلیدواژه
|
achillea millefolium ,type 2 diabetes mellitus ,diabetic nephropathy ,creatinine ,herbal medicine
|
|
آدرس
|
shahrekord university of medical sciences, clinical biochemistry research center, basic health sciences institute, iran, rafsanjan university of medical sciences, school of medicine, immunology of infectious diseases research center, research institute of basic medical sciences, department of immunology, iran
|
|
پست الکترونیکی
|
vahid.mshahrokhi@gmail.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|